Literature DB >> 11642016

[Comparison of 2 administration protocols (continuous or discontinuous) of a time-dependent antibiotic, Tazocin].

S Pédeboscq1, B Dubau, S Frappier, V Hernandez, D Veyssières, S Winnock, J P Pometan.   

Abstract

A predictive parameter of beta-lactam therapeutic efficacy is the time (T > MIC) while antibiotic serum concentrations are above the MIC of suspected bacteriological agents. This led us to carry out a randomised open study to compare the usually used intermittent administration of Tazocin (three injections of 4 g/0.5 g a day) and continuous perfusion of 12 g/1.5 g a day by calculating these T > MIC. Patients from digestive reanimation department were randomised within two arms: continuous or intermittent administration. Sixteen takings of blood were executed over a forty-hour period. After liquid/liquid extraction, piperacillin and tazobactam serum concentrations were determined by HPLC with a reversed phase column (C18) and a UV spectrophotometry detection. Then, from the time-concentration curves we have evaluated the T > MIC for an enterobacteria (MIC = 8 micrograms/mL) and for Pseudomonas (MIC = 16 micrograms/mL). Concerning intermittent administration T > MIC were 74% (c > MICenterobacteria) and 62% (c > MICPseudomonas). These percentages in the continuous arm were 100% (c > MICenterobacteria) and 99% (c > MICPseudomonas). Tazobactam concentrations were low and even undetectable between each injection in the intermittent administration arm. This was not found within the continuous administration arm. In conclusion, for the intermittent administration, we observed some long periods occurring before each injection while antibiotic concentrations were under the MIC of most bacteria. During these same periods tazobactam concentrations were under the efficacy threshold. These periods were not observed within the continuous administration arm.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11642016     DOI: 10.1016/s0369-8114(01)00210-3

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  5 in total

Review 1.  Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections.

Authors:  Jennifer Shiu; Erica Wang; Aaron M Tejani; Michael Wasdell
Journal:  Cochrane Database Syst Rev       Date:  2013-03-28

2.  Continuous beta-lactam infusion in critically ill patients: the clinical evidence.

Authors:  Mohd H Abdul-Aziz; Joel M Dulhunty; Rinaldo Bellomo; Jeffrey Lipman; Jason A Roberts
Journal:  Ann Intensive Care       Date:  2012-08-16       Impact factor: 6.925

3.  Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?

Authors:  Bruno Van Herendael; Axel Jeurissen; Paul M Tulkens; Erika Vlieghe; Walter Verbrugghe; Philippe G Jorens; Margareta Ieven
Journal:  Ann Intensive Care       Date:  2012-07-02       Impact factor: 6.925

Review 4.  Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials.

Authors:  Pranita D Tamma; Nirupama Putcha; Yong D Suh; Kyle J Van Arendonk; Michael L Rinke
Journal:  BMC Infect Dis       Date:  2011-06-22       Impact factor: 3.090

5.  Continuous versus intermittent administration of piperacillin-tazobactam in intensive care unit patients with ventilator-associated pneumonia.

Authors:  Fanak Fahimi; Somayeh Ghafari; Hamidreza Jamaati; Shadi Baniasadi; Payam Tabarsi; Arvin Najafi; Arnavaz Akhzarmehr; Seyed Mohammad Reza Hashemian
Journal:  Indian J Crit Care Med       Date:  2012-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.